Skip to main content

Table 1 Best evidence synthesis of clinical markers

From: Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review

Category

Marker

Good/fair quality studies

Poor quality studies

Evidence

Comorbidities

Diabetes mellitus

2x no association [18, 19]

 

Strong evidence of no association

Diarrhea

2x no association [18, 20]

1x no association [21]

Strong evidence of no association

Infection requiring antibiotics

1x positive association [20]

1x no association [18]

 

Conflicting evidence

Uveitis

1x positive association [18]

 

Moderate evidence of positive association

Disease characteristics (general)

(worsening) Fatigue

1x positive association [22]

 

Moderate evidence of positive association

Worsening function

1x positive association [22]

 

Moderate evidence of positive association

Younger age at Pso onset

2x positive association [23, 24]

1x no association [25]

 

Conflicting evidence

Disease characteristics (joints)

Arthralgia in women (not men)

1x positive association [22]

 

Moderate evidence of positive association

Cortical vBMD entheseal

1x negative association [26]

 

Moderate evidence of negative association

Heel pain

1x positive association [22]

 

Moderate evidence of positive association

(worsening) Stiffness

1x positive association [22]

 

Moderate evidence of positive association

Structural entheseal lesion

1x positive association [26]

 

Moderate evidence of positive association

Worsening pain

1x positive association [22]

 

Moderate evidence of positive association

Disease characteristics (skin/nails)

Duration of Pso

1x no association [27]

1x positive association [28]

Conflicting evidence

Intergluteal lesions

1x positive association [25]

 

Moderate evidence of positive association

Nail pitting

1x positive association [18]

 

Moderate evidence of positive association

Psoriatic nail lesion

3x no association [18, 19, 27]

1x positive association [25]

 

Strong evidence of no association

Scalp lesions

1x no association [27]

1x positive association [25]

 

Conflicting evidence

Severity of Pso

2x no association [20, 27]

3x positive association [18, 22, 25]

1x positive association [28]

Conflicting evidence

Fertility

Fertility treatment

1x no association [20]

1x no association [21]

Moderate evidence of no association

Hormone replacement therapy

1x no association [20]

1x no association [21]

Moderate evidence of no association

Menopause

3x no association [18,19,20]

 

Strong evidence of no association

Oral contraceptives

2x no association [19, 20]

1x no association [21]

Strong evidence of no association

Pregnancy

1x no association [20]

1x negative association [19]

1x no association [21]

Conflicting evidence

Intoxication

Alcohol consumption

3x no association [18,19,20]

1x mixed results [29]

3x no association [21, 28, 30]

Strong evidence of no association

Current smoking

2x negative association [20, 31]

2x no association [18, 29]

1x negative association [28]

1x no association [32]

Conflicting evidence

Past smoking

3x no association [18, 29, 31]

1x negative association [20]

2x no association [28, 32]

Strong evidence of no association

Smoking intensity

 

1x positive association [32]

Limited evidence of positive association

Medication

Corticosteroids use

1x positive association [19]

 

Moderate evidence of positive association

Influenza vaccination

1x no association [20]

1x no association [21]

Moderate evidence of no association

Methotrexate use

2x no association [18, 19]

 

Strong evidence of no association

Retinoid use

1x positive association [18]

 

Moderate evidence of positive association

Rubella vaccination

1x no association [20]

1x positive association [21]

Conflicting evidence

Tetanus vaccination

1x no association [20]

1x no association [21]

Moderate evidence of no association

Patient characteristics

Age

4x no association [20, 22, 25, 27]

 

Strong evidence of no association

BMI

3x no association [18, 22, 27]

2x positive association [29, 33]

1x positive association [34]

Conflicting evidence

BMI at 18 years

1x positive association [24]

1x no association [34]

Conflicting evidence

Patient reported family history of PsA

3x no association [18, 20, 27]

 

Strong evidence of no association

Female sex

3x no association [20, 22, 27]

1x no association [28]

Strong evidence of no association

Hip circumference

 

1x positive association [34]

Limited evidence of positive association

University or high school level of education

1x no association [20]

1x negative association [18]

 

Conflicting evidence

Waist circumference

 

1x positive association [34]

Limited evidence of positive association

Waist-hip ratio

 

1x positive association [34]

Limited evidence of positive association

Weight increase from 18 years

 

1x positive association [34]

Limited evidence of positive association

Physical stress

Lifting heavy loads

1x positive association [20]

 

Moderate evidence of positive association

Trauma

2x no association [19, 20]

1x mixed results [21]

1x positive association [35]

Strong evidence of no association

Psychological distress

Anxiety/depression

2x no association [18, 20]

1x positive association [36]

1x no association [21]

Conflicting evidence

Change in work status

1x no association [20]

1x no association [21]

Moderate evidence of no association

Death of a family member

1x no association [20]

1x no association [21]

Moderate evidence of no association

Move to a new house

1x no association [20]

1x positive association [21]

Conflicting evidence

Psychological distress

1x no association [22]

1x no association [19]

 

Strong evidence of no association

  1. A positive association is defined as a higher risk of PsA when the marker is present/increased/higher. A negative association is defined as a lower risk of PsA when the marker is present/increased/higher
  2. BMI body mass index, PsA psoriatic arthritis, Pso psoriasis, vBMD volumetric bone mineral density